The hypothesis of a subclinical infection resulting from biofilm deposition around the implant prosthesis has been suggested as an important cause of capsular contracture. 3 Contamination is thought to be secondary to skin contamination upon insertion of the implant or via seeding from the implant pocket from bacterial ductal colonies. Various measures to prevent such contamination are being utilized including implant and pocket irrigation with iodine or triple antibiotic solution prior to insertion of the prosthesis. 4 The current measures however still do not address preventing electrostatic attraction from air particulate matter upon removing the breast implants from its sterile packaging. The use of laminar airflow in operating theatres may reduce the particulate count and thermal plume within the operating theatre 5 but does not truly eliminate inadvertent deposition of airborne microscopic particulate matter on medical devices 6 such as breast implants. These particulate matters which may or may not be pathogenic are attracted to the implant surface via electrostatic charges. 7 Ultimately this may contribute to a higher risk of infection (including subclinical infection) and/or capsular contracture.
TECHNICAL DETAILS
The authors present an effective and simple intraoperative method for prevention of electrostatic contamination of breast implants prior to removal of the implant from its sterile packaging prior to definitive insertion into the breast pocket. The concept and methodology was first proposed and shown to the lead author (L.S.K.) by Ivo Pitanguy and full credit is given to late Pitanguy for this ingenious idea that to our knowledge has never been published before. A video demonstration accompanies this text to illustrate this method succinctly (Video 1, available as Supplementary Material at www.aestheticsurgeryjournal.com).
Opening the sterile cover of the implant immediately exposes the implant to airborne electrostatic particles. This is proven by placing the implant near finely cut pieces of sterile paper; in this case cut pieces of sterile glove cover material is used. The implant exerts an electrostatic field that attracts the finely cut papers to its surface (Figures 1-2) . We have repeated this experiment with both silicone and saline varieties of smooth, textured and polyurethane coated implants of sizes ranging from 180 to 500 cc with similar results. The air in the operating room (OR) may contain many fine microscopic particles that may also be attracted to the surface area of the implant; ironically even more so in a laminar air flow designed theatre. Laminar flow ORs more effectively lift particulate matter and hold some in suspension, and any electrostatic attractant forces would therefore be more effective meaning electrostatic contamination would be higher. 8 into private clinics in the Netherlands showed, even in a western country like this, 28% of 92 clinics visited, breast implants were placed during surgery in a class II OR instead of a class I OR, with the latter having laminar air flow. 9 Paradoxically, the premise of preventing contamination in a class I OR may contribute to higher levels of electrostatic forces which may have draconian effects on electrostatic contamination of the implants. With this regard; class II ORs are safer.
To circumvent this electrostatic contamination, we first take a syringe with 21G needle filled with triple antibiotic or iodine solution and inject it directly through the paper cover of the sterile package (Figure 3 ). Then we tilt the package back and forth to immerse and cover the implant with the antibiotic or iodine solution. The removed implant now does not attract any finely cut paper as the former approach (Figures 4-5 ). This method prevents any microscopic particulate matter from adhering to the implant prior to removing it from the sterile packaging.
Every package opened in the OR (including instruments or any prosthesis, including orthopaedic joint replacements) need to be considered at risk from electrostatic forces. Hence the concept of this method can be extrapolated to other types of surgeries where biomaterials and prosthesis are inserted intraoperatively.
OUR EXPERIENCE
The lead author has been utilizing this method for preventing electrostatic contamination of breast implants since February 2014 until present with a total of 113 cases (age range, 16-62 years) being operated for primary/secondary augmentation mammaplasties and augmentation mastopexies. The second author (H.P.S.) has recently implemented this method (since September 2016) for all primary and secondary surgical cases involving the use of breast implants. This method is appropriate for all patient types including both aesthetic 
OUTCOMES
Both authors report a 0% infection rate and capsular contracture in all cases up to present. To the best of our knowledge there are no known complications arising from the use of this method to prevent electrostatic contamination of breast implants intraoperatively. It is however important that the surgeon takes care not to inadvertently pierce the breast implant with the needle used to inject the antibiotic solution directly through the paper cover of the sterile package. This has however never happened in the authors' experience.
COSTS
The implementation of this method is practically cost-free. Therefore, it can be implemented immediately by any practicing surgeon without adversely affecting revenue or capital resources.
CONCLUSION
It is the authors' belief that this method can further reduce the incidence of subclinical infection and ultimately also the incidence of capsular contracture. This is even more important in breast reconstruction with implants where infection rates range up to 24%. 10 This simple but effective intraoperative method may be added to the current armamentarium for prevention of capsular contracture in augmentation mammaplasty and implant based breast reconstruction.
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